Shanghai Kaibao Pharmaceutical CO.,Ltd announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 475.581 million compared to CNY 787.880 million a year ago. Operating income was CNY 94.435 million compared to CNY 180.445 million a year ago. Net income was CNY 76.941 million compared to CNY 152.997 million a year ago. Basic earnings per share from continuing operations was CNY 0.0736 compared to CNY 0.1463 a year ago.